Localization of Idd11 using NOD congenic mouse strains: elimination of Slc9a1 as a candidate gene

Citation
Tc. Brodnicki et al., Localization of Idd11 using NOD congenic mouse strains: elimination of Slc9a1 as a candidate gene, IMMUNOGENET, 51(1), 2000, pp. 37-41
Citations number
26
Categorie Soggetti
Immunology
Journal title
IMMUNOGENETICS
ISSN journal
00937711 → ACNP
Volume
51
Issue
1
Year of publication
2000
Pages
37 - 41
Database
ISI
SICI code
0093-7711(200001)51:1<37:LOIUNC>2.0.ZU;2-3
Abstract
Type 1 diabetes is a multigenic autoimmune disease, the genetic basis for w hich is perhaps best characterized in the nonobese diabetic (NOD) mouse mod el. We previously located a NOD diabetes susceptibility locus, designated I dd11, on mouse Chromosome (Chr) 4 by analyzing diabetic backcross mice prod uced after crossing NOD/Lt with the nondiabetic resistant strain C57BL/6 (B 6) strain. In order to confirm Idd11 and further refine its location, three NOD congenic mouse strains with different B6 derived intervals within Chr 4 were generated. Two of the congenic strains had a significant decrease in the cumulative incidence of diabetes compared with NOD/Lt control mice. Th e third NOD congenic strain, containing a B6 interval surrounding the Slc9a 1 locus, was not protected against diabetes. These results define a new dis tal boundary for Idd11 and eliminate the Slc9a1 gene as a candidate. The Id d11 locus has now been definitively mapped to a 13cM interval on mouse Chr 4.